NEW YORK, April 19 (GenomeWeb News) - Shares in Sequenom were trading up 10.3 percent, or $.10, at $1.11 in early afternoon trading on news that the company has developed a process to identify epigenetic markers in lung cancer.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.